Researchers have developed a synergistic cancer nanovaccine packing DNA and RNA sequences that modulate the immune response, along with anti-tumor antigens, into one small nanoparticle. The nanovaccine produced an immune response that specifically killed tumor tissue, while simultaneously inhibiting tumor-induced immune suppression to block lung tumor growth in a mouse model of metastatic colon cancer.

Via:: http://feeds.sciencedaily.com/~r/sciencedaily/matter_energy/nanotechnology/~3/mPq8UWIzPm8/171129163851.htm

‘Swiss army knife’ nanovaccine carries multiple weapons to battle tumors

Leave a Reply